ArticleCase reports in ophthalmology
Epiretinal Membrane Surgery for a Patient with Dyskinesia Related to Parkinson's Disease Using Intravenous Dexmedetomidine Administration.
Article in Case reports in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Therapeutic Potential of Dexmedetomidine in Neuropsychiatric Disorders: From the Bench to the Clinic.Current neuropharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
General anesthesia is usually selected when patients cannot remain still during surgery with local anesthesia. However, damage to the lungs from positive pressure ventilation under general anesthesia is a major concern in patients with Parkinson's disease. We report a case in which dyskinesia related to Parkinson's disease was attenuated by intravenous dexmedetomidine (DEX) administration, following which epiretinal membrane (ERM) and inner limited membrane peeling could be smoothly performed. A 68-year-old woman with systemic dyskinesia related to Parkinson's disease underwent cataract surgery for her right eye with local anesthesia (topical anesthesia with 4% lidocaine and sub-Tenon's anesthesia with 2% lidocaine and 30% nitrous oxide inhalation). During the surgery, continuous involuntary facial movement related to Parkinson's disease remained uncontrollable. One week later, she underwent cataract surgery and pars plana vitrectomy for the ERM of her left eye. In addition to local anesthesia (topical anesthesia with 4% lidocaine and retrobulbar anesthesia with 2% lidocaine and 30% nitrous oxide inhalation), the patient received intravenous DEX, which halted movement from the beginning of surgery until the end. Therefore, ERM surgery was performed without the influence of dyskinesia. This case highlights that intravenous DEX administration can inhibit dyskinesia related to Parkinson's disease during ERM surgery, which is among the most delicate microscopic procedures performed in ophthalmological settings. Additional studies are required to examine the actual effectiveness of DEX administration in patients with Parkinson's disease-related dyskinesia undergoing ophthalmological procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.